KGA-4066
KGA-4066 is a novel non-ATP-competitive CDK2 inhibitor. KGA-4066 inhibits CDK2/Cyclin A2 with an IC50 value of 236.7 nM, disrupts their interaction, promots CDK2 degradation via the lysosomal pathway. KGA-4066 has anticancer activity against hepatocellular carcinoma.
For research use only. We do not sell to patients.
- Formula: C30H37ClO5
- Molecular Weight:513.06
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
IC50: 236.7 nM (CDK2/Cyclin A2)[1]
Chemical Information
-
Molecular Weight 513.06
-
Formula C30H37ClO5
-
SMILES
C[C@]1(O)CC[C@@H]2[C@H](OC(C2=C)=O)C3=C1[C@H]4C[C@]3(C)[C@]([C@H]5[C@H](O6)C7C(CC[C@@H](Cl)[C@]7(C)CC5)=C)(C4)C6=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KGA-4066 Related Classifications
HY-180222 Related Classifications
Powered by Bioz